FHTX
Foghorn Therapeutics Inc.
Price:  
4.22 
USD
Volume:  
79,265.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

FHTX WACC - Weighted Average Cost of Capital

The WACC of Foghorn Therapeutics Inc. (FHTX) is 6.3%.

The Cost of Equity of Foghorn Therapeutics Inc. (FHTX) is 9.00%.
The Cost of Debt of Foghorn Therapeutics Inc. (FHTX) is 5.00%.

Range Selected
Cost of equity 7.40% - 10.60% 9.00%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.6% - 7.1% 6.3%
WACC

FHTX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.77 1.03
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.40% 10.60%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 5.6% 7.1%
Selected WACC 6.3%